The U.S. Food and Drug Administration (FDA) has announced significant advancements in medical treatments, including the approval of a novel gene therapy for a rare eye disease ...
In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...